On (b)(6) 2019, the patient visited the implanting clinician and reported pain at the implant site.The patient has a history of infection related to their previous implantable stimulator (different manufacturer).The implanting clinician decided to take blood tests.The results came back normal; however, the implanting clinician did not want to discard the possibility of an infection.The patient was sent home the same day without treatment and was instructed to follow up if the area was worse.The patient-maintained contact with the cr and was reprogrammed.On (b)(6) 2019, the implanting clinician contacted the cr to report the device was not providing therapy and was going to pull the trial stimulators due to a potential infection.Cultures were taken to determine if infection was present.On (b)(6) 2019, implanting clinician met with the patient and scheduled a revision for (b)(6) 2019.Infection culture results came back negative.The skin irritation was determined to be caused by the migration, making this an erosion.The patient is still using the stimulators and it is providing therapy.On (b)(6) 2020, the cr reported that the patient is doing well.The patient is currently working with three new programs.
|
Stimwave quality has investigated the details for a reported skin irritation due to erosion (thought to be infection), submitted to the stimwave complaint system on (b)(6) 2019, by clinical representative (cr), in (b)(6).The exact awareness date of this issue is unknown.
|